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Abstract
Background: Total tooth loss (edentulism) can be a debilitating condition, impacting on ability to chew, speak and
interact with others. The most common treatment is with complete removable dentures, which may be successful,
but in the lower jaw, bone resorption that worsens over time makes denture-wearing difficult. Two dental implants
in the mandible to retain the lower denture has been advocated as the gold standard of treatment, but has not
been universally provided due largely to financial constraints and also patient fear. Mini implants (MI) are cheaper
and less invasive than conventional implants (CI), but may not have equivalent longevity. Therefore, it is unknown
whether they represent a cost-effective treatment modality over time. The aim of this pilot randomised controlled
trial was to assess the feasibility of carrying out a trial on this cohort of patients, and to inform the study design of
a large multicentre trial.
Methods: Forty-six patients were randomly allocated to receive either two mini implants or two conventional
implants in the mandible to retain their lower dentures. Quality of life (QoL) questionnaires, pain and anxiety scores,
and an objective “gummy jelly” chewing test were carried out at multiple timepoints, along with detailed health
economics information. Implants were placed one-stage, and an early loading protocol was utilised. Patients were
reviewed 8 weeks post-placement, and finally at 6 months. Implant failure, recruitment and retention rates were
recorded and analysed.
Results: The pilot study demonstrated that it is possible to recruit, randomise and retain edentulous (mainly elderly)
patients for an implant trial. We recruited to target and retention rates were acceptable. The large number of
questionnaires was onerous for participants to complete, but the distribution of scores and feedback from participants
helped inform the choice of primary and secondary outcomes in a full trial. The chewing test was time-consuming and
inconsistent. Implant failure rate was low (1/46). The data on indirect costs gathered at every visit was viewed as
repetitive and unnecessary, as there was little or no change between visits.
Conclusions: The pilot study has shown that acceptable recruitment and retention rates are achievable in this population
of patients for this intervention. The results provide valuable information for selection of outcome variables and sample size
calculations for future trials.
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Background
The World Health Organisation (WHO) considers eden-
tulism (total tooth loss) a physical disability [1, 2]. The
majority of edentulous patients are able to chew their
food with complete dentures but over time, the lower
jaw becomes resorbed and there is less bone to retain
the lower denture. This makes it more difficult to retain
the denture which causes problems for the denture-
wearer, such as difficulties in eating and speaking, which
may lead to a change in lifestyle, as those affected be-
come embarrassed to socialise and eat with friends [3].
Furthermore, their inability to chew results in poorer
food choices [4, 5] with many opting for highly calorific
softer foods that are easier to eat. This undoubtedly af-
fects their nutrition and thus general health. All of these
factors have been shown to impact greatly on a patient’s
quality of life [6].
The dental literature is awash with papers showing sig-
nificant improvements in quality of life in edentulous
patients who have two dental implants placed in their
lower jaw to secure their lower dentures [6–15]. Indeed
there are national and international consensus state-
ments that this treatment modality should be the first
line of treatment for patients with an edentulous man-
dible [16, 17]. However, this treatment is costly for both
individual patients and health services around the world
to provide. Furthermore, surgery to place implants is in-
vasive [18], and this can pose a barrier to treatment even
when provided free of charge [19, 20]. Edentulous pa-
tients are often older people (over 65 years) and may
have significant bone resorption in their lower jaw and
complex medical histories, which may affect their suit-
ability for implant treatment.
Mini dental implants have been in use for the last
12 years [21–36] and offer a number of advantages over
conventional implants: they have a smaller diameter
(<2.4 mm) and are often made of a titanium alloy (Ti 6Al-
4 V ELI) as opposed to commercially pure titanium (type
4) used in conventional dental implants. They are often
placed using a minimally invasive technique, resulting in
less post-operative pain [37]; and are therefore approxi-
mately a quarter of the cost of current conventional alter-
natives [21, 22]. These advantages need to be considered
against a potentially higher failure rate [38] when com-
pared to conventional implants, which have an impres-
sively high survival rate over 10 years [15], and possibly a
need for more intensive on-going maintenance [39].
There is a lack of high quality evidence of the effects
of mini implants compared to conventional implants in
retaining mandibular complete dentures [39, 40]. The
primary aim of this study was to assess the feasibility of
conducting a large surgical randomized controlled trial
of mini versus conventional implants in a population of
patients who can benefit from an implant- retained
lower denture. The identified key areas of uncertainty to
be explored in this trial focused upon the processes of
recruitment and retention of participants, choice of clin-
ical, quality of life and cost outcome measures and their
method of capture. The objectives were specifically to
determine:
 The proportion of referred patients that were
eligible to participate, consented to the trial and
provided data at all time-points;
 Whether masticatory functional ability could be
measured using a validated ‘gummy jelly’ chewing test;
 The completeness and variability of using different
instruments to collect data on pain, QoL, implant
failure; and
 How to collect and measure costs
Methods
Design and eligibility criteria
The pilot trial was a two-arm parallel group randomised
controlled pilot trial. Full ethical approval was obtained
from the National Health Service Health Research
Authority, National Research Ethics Service, Research
Ethics Committee (ref: REC 13/NW/0384), and the
study clinicians collected informed consent. All edentu-
lous patients experiencing difficulties with their lower
dentures, referred to the University Dental Hospital of
Manchester or from internal referrals from hospital con-
sultants, were initially screened for eligibility from the
referral letters. Potentially eligible participants were
booked onto consultation clinics for full medical history
and clinical examination. Patients with an edentulous
mandible, with residual mandibular ridge Cawood and
Howell Class V or VI [41] with continued difficulties
eating, even after the provision of new dentures, were
eligible to participate. Patients with a history of bisphos-
phonate therapy or implant treatment, requiring sed-
ation or general anaesthetic for implant placement,
smokers, or patients unable to maintain adequate levels
of oral hygiene were excluded.
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Randomisation
The Clinical Trials Unit centrally randomised patients to
one of two treatment groups with a 1:1 allocation ratio
using random permuted blocks. A study clinician
enrolled participants onto the trial and assigned partici-
pants to interventions according to the randomisation.
The clinician performing the implant placement and
health economist could not be blinded to treatment allo-
cation; the research nurse (who collected masticatory
efficiency and patient rated outcome data) and the trial
statistician were blinded.
Treatment procedures
All patients were given an oral loading dose of 2 mg
Amoxicillin (or 600 mg Clindamycin if allergic to peni-
cillin) as per best current evidence [42]. All patients
were asked to rinse for 60 s with Chlorhexidine (0.2%)
mouthwash (with both dentures removed) and given
local anaesthetic using 2% lignocaine + 1:80,000 adren-
aline infiltrated into the anterior mandible.
Mini-implant (MI)
Two mini implants (3 M® 2.1 mm diameter, 10 mm
length one-piece implant with a square collar and ball
abutment) were placed transmucosally (flapless) in the
interforamina region of the edentulous mandible.
Conventional implant (CI)
Two conventional (ASTRA TECH® Osseospeed 3 mm
diameter, 11 mm length) implants were placed in the
interforamina region of the edentulous mandible. These
were placed after raising soft tissue flaps and drilling
directly into bone. Ball abutments were placed on the
conventional implants in a one-stage surgery approach
to mimic the mini-implant attachment system.
Following surgery, all patients were given oral and
written post-operative instructions and advised not to
wear their lower dentures for 1 week. All patients were
given 24 × 500 mg Paracetamol tablets to take as re-
quired. At 1 week postoperatively participants’ lower
dentures were hollowed out chair-side so they could fit
over the exposed ball abutments. Therefore, lower den-
tures could be worn but the implants were not directly
loaded. At the 2-month review appointment an impres-
sion was taken of the implant ball abutments using a
polyether impression material (Impregum™ Penta™ 3 M
ESPE) in the patient’s lower complete denture. The den-
ture was retrofitted with stud attachments on the same
day by dental laboratory technicians using heat-cured
acrylic.
Outcomes
Multiple outcome measures were assessed in accordance
with the objectives of the study and as per the schedule
below (Table 1). The primary outcomes of this study
were feasibility outcomes. The feasibility of a main trial
using the same study design and protocol was assessed
according to the objectives of the pilot trial: recruitment
and retention of trial participants; use of outcome mea-
sures and collection of cost data.
 The feasibility of recruitment was measured in terms
of eligibility (the proportion of eligible patients from
the number of screened patients), recruitment (the
proportion of recruited patients from the number of
eligible patients), and whether the required sample
size could be met within the designated 12-month
recruitment period. The success of patient retention
was measured in terms of compliance with
randomisation (the proportion of participants
receiving their allocated treatment) completeness
of follow-up (the proportion of patients providing
6 month follow up data). The denominator was
the number of patients randomised.
 The feasibility of using masticatory efficiency as an
effectiveness outcome was assessed as the number of
‘gummy jelly’ samples that were provided, and were
able to be analysed.
 The appropriateness of the different outcome measures
was assessed quantitatively in terms of proportion of
completed questionnaires, and qualitatively in variation,
absence of floor or ceiling effects and variability of
responses over time.
 The feasibility and appropriateness of collecting cost
information was assessed based on the proportions
of completed patient questionnaires (patient costs)
and completed health care costs, and the recording
of unanticipated resource use.
Formal hypothesis testing for effectiveness was not be
undertaken as the aim of a pilot trial is not to assess
effectiveness and as such the study is underpowered for
this purpose.
Sample size
As this was a pilot trial a formal sample size calculation
was not appropriate. We estimated that of those patients
screened and meeting the inclusion criteria, 50% would
agree to participate. A total of 44 patients (22 in each
arm) would have a 95% confidence interval ranging from
35% to 65% of patients who will agree to participate. A
recruitment target was set at 44 patients or 1 year of re-
cruitment, whichever endpoint was reached soonest.
Statistical analysis
It was not our intention to compare treatment groups
and we did not test hypotheses. Cumulative and monthly
(to assess season variation) recruitment figures were
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calculated, as were loss to follow up at 2 and 6 months
post-surgery. Descriptive analyses were undertaken for a
12 month period (covering the period 6 months prior to
the study start and the 6 months follow up) to identify
the total number of referrals, the number and propor-
tion of participants who attended for assessment, and
the number and proportion of patients who required im-
plants after fitting a new set of conventional complete
dentures. Simple descriptive statistics involving calcula-
tion of ranges, frequency distributions and measures of
central tendency and dispersion were used to assess the
completeness and variability of clinical, quality of life
and cost outcome measures collected at each time point.
The health economics analysis presents the resources
recorded and their respective unit costs. Costs were cal-
culated from the National Health Service (NHS) and so-
cial care provider perspective, secondary analysis
includes costs from the patient perspective, and this ap-
proach approximates a societal perspective. The time
trade-off (TTO) measurement for weighting the EQ-5D
was used, as this is the recommended utility weight ad-
vocated by the National Institute for Health and Care
Excellence NICE [43]. The TTO weights are obtained
from Dolan (1997) [44]. The SF-12 was mapped onto
the SF-6D (since the SF-6D has Health-Related QoL
weights). SF-6D weights were obtained from Brazier and
Roberts (2004) [45].
Results
The recruitment and retention of participants from
screening through to 6-month follow-up is shown in
Fig. 1. Of note is that only 81/181 of those referred were
eligible for the study, and of the 73 patients for whom
new complete dentures were made, 12 were relatively
satisfied with their new lower denture and declined fur-
ther treatment. Furthermore, only four patients who
were dissatisfied with their new denture did not want to
be randomised, having a preference for mini-implants
(three patients) or conventional implants (one patient).
Of the 46 patients randomized 43 (93.5%) completed
the trial.
Although the initial plan was to recruit a maximum of
44 participants or as many participants as possible in the
planned 1-year recruitment period, in total 46 patients
were recruited and randomised (further ethical approval
was provided to recruit the additional participants). The
median number of patients recruited per month was
three and the monthly and cumulative recruitment
figures are summarised in Fig. 2. The maximum number
of patients recruited in a single month was six patients
Table 1 Outcome measures and timing of measurement

















‘gummy jelly’ chewing test
X X X
Pain:
Visual Analogue Scale (VAS) or
Verbal Rating Scale (VRS) (0–10)
X X X
Use of analgesics (professionally
and self prescribed) and antibiotics




Indirect costsa X X
Healthcare utilisationa X X X X X
Assessment of adverse eventsa X X X X X
Assessment for possible implant failure X X X
adata also to be collected at unscheduled visits
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(June 2014); the minimum number of patients recruited
was one (February 2014 and September 2014).
During the trial there was one protocol violation.
During analysis it transpired that one patient was taking
bisphosphonates a concomitant medication that that was
not fully disclosed at recruitment. This patient was not
included in the analyses. Table 2 shows the baseline
characteristics of the trial participants.
Table 3 presents the clinical and patient rates of oral
health quality of life outcomes. No participants refused
to take the ‘gummy jelly’ test and we were able to
measure the glucose released from all samples. The pat-
tern of results for the ‘gummy jelly’ test did not reflect
those of the OHIP-20 or subjective assessment of chew-
ing ability (see Fig. 5.) However, due to differences in
batch composition the glucose released at 6 months was
not comparable to baseline or 2 month measures.
Pain VAS scores recorded immediately post-op and
after 1 week post-op are presented in Fig. 3. The range
of scores was wider in the conventional implant group
compared to the mini implant group; this difference in
distribution was most notable 1 week post-operatively.
Fig. 1 Flow diagram showing recruitment and retention
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Clinician and patient reported analgesic consumption,
at face value, was also higher in the CI group compared
to the MI group during the surgical procedure and at
1 week post-surgery.
The results of the OHIP-20 scores are presented in
Fig. 4. There was downward trend in OHIP QoL scores
in both groups at 6-month follow up compared to base-
line suggesting an improvement in oral health related
quality of life.
The denture satisfaction questionnaire records differ-
ent aspects of patient satisfaction with their prosthesis
using a 100 mm VAS. The scales are anchored by the ex-
tremes of potential responses (e.g., not at all satisfied to
extremely satisfied). Higher values indicate a positive
response and improvement. The distributions of re-
sponses for each domain of the prosthesis assessment
questionnaire are shown in Fig. 5.
There were no adverse events reported in the MI
group. CI group had 4 adverse events (8.9%). One was
due to pain, and three due to infection. All were treated
medically with painkillers and antibiotics as appropriate.
One patient died during the follow-up period, from a
condition unrelated to treatment. No other Serious
Adverse Events were recorded.
There was a total of 74 unscheduled visits in 45 pa-
tients (mean 1.7, range 0 to 6): In the MI group there
were 23 implant-related visits, due primarily to problems
with O-ring attachments, and 18 prosthesis-related
visits; in the CI group there were 13 implant-related
visits, 17 prosthesis related visits and 3 visits for other
reasons.
The costs of the MI and C- groups are presented in
Table 4. Mean NHS costs observed over the trial for MIs
were lower than that for CIs (column 1 of Table 4, £296
vs. £688). The MI group had lower observed mean staff
costs (£37 vs. £88), equipment and consumable costs
(£181 vs. £532), and medication costs (£0.23 vs. £4.24).
The MI group had higher observed mean unscheduled
visits costs (£78 vs. £63) (a detailed analysis of all costs
recorded and methods used to generate costs are con-
tained in the Additional file 1).
There was a higher mean patient cost observed for the
MI group (£193 vs. £156) (column 2 of Table 4). Missing
Fig. 2 Bar chart showing actual recruitment versus projected recruitment (line graph)








68.5, 63 to 74
52 to 88
68.1 (8.5)
71, 61 to 74
48 to 79
68.3 (8.9)
70, 62 to 74
48 to 88
Gender 10 male (45.5%) 9 male (39.1%) 19 male (42.2%)
Years edentulous 26.0 (20.8)
32, 3 to 45
1 to 58
20.2 (17.7)
14, 5 to 38
1 to 57
23.1 (19.3)






11, 8 to 14
5 to 17
11.6 (6.6)
9, 6 to 15
5 to 25
11.2 (5.4)
10, 7 to 14
5 to 25
aValues are mean and standard deviation along with median, interquartile range,
minimum and maximum for age, number of years edentulous and anxiety
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data was evident in most patient costs; most patients re-
ported the same costs at each visit and were perplexed
that the same questions were asked at each visit. The
compounding nature of missing data (since there are
three instances of follow ups and numerous unscheduled
visits) resulted in a final complete cost sample of 15 pa-
tients. Of these, the mean observed costs of MI were
lower than that for CI (£481 vs. £814).
Table 5 presents the results of EQ-5D and SF-6D
questionnaires at baseline and at 2 and 6 months assess-
ment. A higher score represents higher health-related
QoL (HRQoL). Data was complete in the sense that no
missing data was apparent aside from those patients
who did not complete the trial. At face value mean base-
line EQ-5D and SF-6D scores were lower for the CI
group compared to the MI group. Mean EQ-5D and SF-
6D scores for both groups showed little variation at
6 months follow-up compared to baseline. Comparisons
of changes in EQ-5D and SF-6D scores from baseline to
6 months assessment for those completing the trial sug-
gest reductions in EQ-5D score for both implant groups.
For SF-6D scores there appears to be higher mean SF-
6D scores at 6 months compared to baseline for the CI
group and a reduction in mean scores for the MI group.
Fig. 3 Distributions of responses to pain outcome
Fig. 4 Distributions of responses to OHIP-20 outcome
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Fig. 5 Distributions for each domain of the prosthesis assessment questionnaire (Baseline, 2 months, 6 months)
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Discussion
Overview of the findings
This paper reports the findings of a National Institute
for Health Research (NIHR)-funded pilot trial, the main
purpose of which was to inform the design and conduct
of future trials. Conventional implants have a long
history and their clinical outcomes have been well docu-
mented [46–50]. Over the last 30 years, successive Adult
Dental Health Surveys [51] have shown that the number
of edentulous patients has fallen dramatically. The
inability to retain a mandibular denture is debilitating,
with dental need falling across the whole population a
case could be made in the UK for NHS resources to be
redirected to address the significant needs of this patient
group. Mini implants could offer the NHS an effective
and affordable means of providing care for this group of
patients as a first line course of treatment. But to make
a convincing case a high-quality, large, multi-centre trial
with adequate follow up is required.
The primary aim of this study was to assess the feasi-
bility of a conducting a large surgical randomised con-
trolled trial as proposed in a population of patients who
can benefit from an implant retained lower denture. The
identified key areas of uncertainty to be explored in this
trial focused upon the processes of recruitment and re-
tention of participants, choice of clinical, QoL and cost
outcome measures and their method of capture.
Our concerns over the willingness of this cohort to be
randomized to different surgical options proved to be
unfounded. We reached our required sample size within
the pre-specified recruitment period, and very few
eligible patients declined to take part in the trial because
of a strong patient preference or unwillingness to be ran-
domised. These results suggest that recruitment of partici-
pants through a major, secondary referral centre is
feasible. Moreover, attrition over the 6 months duration
was minimal (43 out of 46 patients (93.5%) completed the
trial) with only four adverse events reported, all minor in
nature and related to the surgery. However, follow up in
this pilot study was limited to 6-months; in trials with a
predominantly elderly sample some attrition from mortal-
ity unrelated to the intervention can be expected.
Trial participants were accepting of the test of masti-
catory function (‘gummy jelly’ test [52]) as evidenced by
the number of samples provided, but the lack of
consistency in measurement over time suggests that this
measure is underdeveloped. Further development and
evidence of repeatability and reliability is needed before
the test could be used with confidence in a clinical trial.
Table 5 Health-Related Quality of Life HRQoL measures







































































































Values are mean, standard deviation, count, median, interquartile range
Table 4 Cost information
NHS cost Patient cost NHS and
patient cost
Mini implants
Mean 296.09 193.22 480.60
Sd 126.93 119.91 249.89
Count 22 7 7
Median 237.33 178.58 389.19
IQR 218.19 to 370.16 112.70 to 248.09 330.81 to 635.33
Range 194.41 to 736.72 62.73 to 430.23 277.90 to 984.82
Conventional implants
Mean 688.30 155.57 813.99
Sd 124.17 70.68 93.62
Count 23 8 8
Median 655.31 157.89 823.17
IQR 628.13 to 687.45 106.73 to 198.26 750.10 to 860.51
Range 585.75 to 1189.69 54.07 to 264.72 676.53 to 967.84
Overall
Mean 496.56 173.14 658.41
Sd 233.90 95.07 246.54
Count 45 15 15
Median 607.63 170.26 696.81
IQR 239.68 to 656.03 112.70 to 222.36 389.19 to 847.45
Range 194.41 to 1189.69 54.07 to 430.23 277.90 to 984.82
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All participants provided responses to pain outcome at
all time-points. The data suggests we could expect to
find a large difference in short-term post-operative pain
scores between the groups in a definitive trial. Descrip-
tively, the pain scores of participants in the CI group
were substantially higher than participants in the MI
group at 24 h and 7 days post-surgery. It would seem
that 7 days post-surgery would be the optimal time for
measurement and little is to be gained from measuring
at both 24 h and 7 days.
Our Public Patient Involvement (PPI) group strongly
recommended QoL as a primary outcome measure for
any future trials in this area. Adherence to the NICE
guidance for health technology appraisal requires health
effects to be expressed in Quality Adjusted Life Years
[43]. A key finding from our research is that the com-
ponents of the generic EQ-5D and SF-6D HRQoL
measures seem to show poor responsiveness to oral
health-related changes in quality of life and many par-
ticipants queried the relevance of the questions in
these measures to an oral health intervention. A full
trial may wish to utilise only one of the HRQoL mea-
sures, our data suggests SF-6D may provide some
variability in the different implant groups but the EQ-
5D is the preferred measure of HRQoL to aid in
consistency when comparing the health effects across
appraisals and so should be the measure of choice to
use in future trials [43].
Data indicated that the OHIP-20 measure [3, 53, 54]
and the individual items of the Assessment of Prosthesis
scale [7] were sensitive to changes before and after
placement of implants. The Assessment of Prosthesis
scale performed as expected, with improvements be-
tween pre and post implant placement in both groups,
but no apparent distinction between the two groups re-
garding ease of general satisfaction, cleaning, aesthetic
and oral conditions. Satisfaction level was high in both
groups after fitting the implants. Ability to speak, the
level of comfort, stability of the dentures, perception of
the chewing ability and function showed similar im-
provement in both groups pre and post implant place-
ment. From a trials design perspective the lack of a
single summary statistic to summarise each individual’s
response means that this instrument in its entirety can-
not be used to calculate a trial sample size but the indi-
vidual items of this measure particularly, subjective
assessment of chewing ability, can provide valuable in-
formation as a secondary outcome measure in the ab-
sence of well-validated objective measures.
Responses to the OHIP questionnaire illustrated the
expected improvement in oral health-related QoL and
the pattern of responses in each group was very similar.
This could indicate either that the effects of the inter-
ventions are indeed very similar, or that the instrument
is insufficiently sensitive to detect any differences be-
tween the groups. Our view is that survival should be the
primary outcome measure of a future multi-centre trial.
This is the primary outcome measure of the majority of
implants trials reported in Cochrane systematic reviews
[42, 55–59] and will be the key determinant of clinical and
economic outcomes. The literature suggests that mini
implants have a lower survival rate than conventional im-
plants [29, 34, 38, 40, 60, 61] but from the data we present
seem less expensive to place and also to replace if they fail.
Studies [34, 60, 61] also suggest that if an implant is going
to fail it is likely to happen in the first 2–3 years, suggest-
ing that follow up period for future trials could be
confined to 3 years, which would help contain costs. Al-
though in this pilot trial follow-up was limited to
6 months, implant failure was rare, with only one failure
of a single implant in the mini implant group and no
failures in the conventional implant group. A subsequent
audit of longevity of mini implants placed, involving all
cases completed in University Dental Hospital of Man-
chester Restorative Department over a 92-month period,
indicates that most failures occur in the first 2–3 years fol-
lowing placement. A low event rate would mean that a
substantial number of participants would be required to
achieve adequate power for a Randomised Controlled
Trial (RCT) if implant failure is the primary outcome.
The pilot trial provided important information with re-
gard to the health economics of implant-retained dentures.
Any difference in costs appears to be driven by the differ-
ences in implant (materials) costs and staff costs (reflected
in staff time). Large differences in staff costs, equipment
and consumable costs were evident between the groups but
little difference in medication costs. The number of
unscheduled visits amount to 41 for the mini implant
group and 33 for the conventional implant group. Our PPI
group recommended a shorter, single measure of indirect
(patient-borne) costs should be used in a full trial. Un-
scheduled visit costs to the NHS and medication costs did
not substantially differ between groups and neither did
patient costs (travel, time off work etc.). This strongly sug-
gests that in future studies measurement of costs should be
mainly restricted to direct costs of treatment, whether that
is borne by the state, insurance companies or individual
patients. One issue that our PPI group raised, which is
important for future trials to consider, is the costs of
ongoing maintenance of implants in primary care. Pa-
tients reported difficulty in finding providers of on-
going care and also the high costs of maintenance
both of which need to be measured and factored into
health economic analyses of future trials.
Strengths and limitations
This trial had narrow inclusion criteria; only patients
with the most atrophic mandibles were invited to
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participate (Cawood and Howell Class V or VI [41]).
However, in the screening process summarised in the
CONSORT flow diagram (Fig. 1.) of the 99 patients
who were ineligible for inclusion 48 were excluded
because their mandibular ridge was Class IV or better,
but these patients still had problems retaining their
lower denture. Also there is evidence [62] to demon-
strate that placement of implants slows down bone
resorption and so reduces the clinical problems faced
by surgeons and prosthodontists. These findings
strongly suggests that many more patients could
benefit from implants than patients with Class V or
VI ridges and points to the need for widening inclu-
sion criteria in future large, multi-centre pragmatic
trials. Broadening inclusion criteria exclusion criteria
could result in a higher recruitment rate and increase
applicability of findings.
Other than implant failure and chewing ability, we
limited our measurements to patient reported outcomes.
The rationale behind this choice was that we wanted to
ensure that in addition to clinically important outcomes,
we captured outcomes that were important to patients.
There was uncertainty as to what patient reported out-
comes would be acceptable and useable with elderly
people in a secondary care setting. Conversely, there is a
consensus on clinically important outcomes such as fail-
ure of the denture superstructure retained by the im-
plants (total replacement or refurbishment needed),
quality and quantity of peri-implant bone. Such mea-
surements are routinely taken in secondary care (where
the full trial would be undertaken) and so uncertainty
surrounding the use of these outcome measures within
an RCT is minimal.
Although the standard practice is the placement of four
or more mini implants in the interforaminal region [26,
28–30, 32, 36], this study trialled the use of two, which
has been shown in clinical case studies and in previous
studies [25, 31] to provide equivalent retention to the rec-
ommended four. A recent RCT compared 4 mini implants
with 2 mini implants with 2 conventional [63]. Further tri-
als are required to assess the costs effectiveness of 2 versus
4 implant retained lower dentures. Although it could be
argued that if mini implants fail they can be readily and
cheaply replaced, however this assumption needs to be ro-
bustly evaluated in future trials.
This was a pilot trial; its purpose was to ascertain
whether a full trial would be feasible and justified and to
collect information to inform the design and conduct of
subsequent trials. Our trial has shown that a full evalu-
ation of ‘which is more cost-effective, mini implants or
conventional implants to retain a lower denture?’ using
the proposed design and methods we employed is feasible.
The data suggest that mini implants are cheaper, have less
post-operative pain and less complications than
conventional implants whilst producing similar QoL im-
provements. However, the follow up period was too short
to assess implant survival and long term cost
effectiveness. The study was also restricted to one site and
to have greater external validity, multi-centre trials are re-
quired in different populations with different care
providers.
Conclusions
Recruitment and retention of sufficient, eligible patients
to a trial within a realistic timescale is possible. There
are limitations in using generic and ‘disease-specific’
QoL measures to evaluate effectiveness in this context.
Implant survival is important for patients and has a
major impact on clinical effectiveness and costs and
should therefore be considered as a primary outcome
measure. Outcomes should be assessed at 7 days post
operatively (pain) and 6 monthly intervals (implant sur-
vival) following implant placement.
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